-transparent.png){kind=logo}
Fenpropimorph-resistant mutants of Saccharomyces cerevisiae were isolated by a gradient selection procedure. The mutants were cross-resistant to other morpholines (fenpropidin, dodemorph, tridemorph) and 15-azasterol, but were susceptible to azoles (miconazole, clotrimazole, ketoconazole) and nystatin. In the absence of fenpropimorph, the major sterol produced by the mutants and the parental strain was ergosterol. In the presence of fenpropimorph, ignosterol (ergosta-8,14-dien-3 beta-ol) was the major sterol produced by the mutants and the parental strain. The resistance to fenpropimorph involves two recessive genes, each of which allows a semiresistance, when they are isolated apart from one another. Strain JR4 (erg3 erg11), which produces 14-methylfecosterol [14 alpha-methyl-ergosta-8,24(28)-dien- 3-beta-ol) as the major sterol in the presence or absence of fenpropimorph, was also found to be resistant to the drug. The growth inhibitory effect of fenpropimorph on wild-type cells appears to be linked to the production of ignosterol. The uptake of exogenous sterol by wild-type cells was greatly enhanced in the presence of fenpropimorph. The growth inhibition caused by fenpropimorph could only be overcome with bulk levels of exogenous C-5,6-unsaturated sterols.
R T Lorenz, and
L W Parks
November 1979,
Molecular & general genetics : MGG,
R T Lorenz, and
L W Parks
April 1976,
Genetics,
R T Lorenz, and
L W Parks
March 2002,
Applied microbiology and biotechnology,
R T Lorenz, and
L W Parks
October 1973,
FEBS letters,
R T Lorenz, and
L W Parks
December 1985,
Molecular and cellular biology,
R T Lorenz, and
L W Parks
September 2013,
The Biochemical journal,
R T Lorenz, and
L W Parks
January 2005,
Molecular microbiology,
R T Lorenz, and
L W Parks
December 1981,
Current genetics,
R T Lorenz, and
L W Parks
October 1982,
Current genetics,
R T Lorenz, and
L W Parks
May 1973,
Biochimie,
